首页>
外国专利>
Treating Ephrin Receptor A2 (Epha2) Positive Cancer with Targeted Docetaxel-Generating Nano-Liposome Compositions
Treating Ephrin Receptor A2 (Epha2) Positive Cancer with Targeted Docetaxel-Generating Nano-Liposome Compositions
展开▼
机译:靶向产生多西他赛的纳米脂质体组合物治疗Ephrin受体A2(Epha2)阳性癌症
展开▼
页面导航
摘要
著录项
相似文献
摘要
EphA2 targeted doxorubicin generating nano-liposomes are useful in the treatment of cancer overexpressing EphA2, alone or in combination with chemotherapeutic agents such as gemcitabine or carboplatin.
展开▼